Fléchon A - Search Results

1

[Management of side effects associated with antiangiogenic treatment in renal cell carcinoma].

Fléchon A, Boyle H, Négrier S. Fléchon A, et al. Bull Cancer. 2010;97:73-82. doi: 10.1684/bdc.2010.1072. Bull Cancer. 2010. PMID: 20418206 French.

2

[High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].

Fléchon A, Biron P, Philip I, Blay JY, Droz JP. Fléchon A, et al. Bull Cancer. 1999 Apr;86(4):391-9. Bull Cancer. 1999. PMID: 10341344 Free article. French.

3

[Is still there an indication for high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?].

Fléchon A, Droz JP. Fléchon A, et al. Bull Cancer. 2001 Sep;88(9):852-7. Bull Cancer. 2001. PMID: 11604357 Free article. Review. French.

4

[Study of the hormone-refractory prostate cancer clinical practice in an anti-cancer center].

Zufferey L, Roques B, Fléchon A, Droz JP. Zufferey L, et al. Among authors: flechon a. Bull Cancer. 2001 Dec;88(12):1213-21. Bull Cancer. 2001. PMID: 11792613 Free article. French.

5

[Management of advanced seminoma: retrospective study of 96 patients].

Bompas E, Fléchon A, Biron P, Droz JP. Bompas E, et al. Among authors: flechon a. Bull Cancer. 2002 Oct;89(10):877-85. Bull Cancer. 2002. PMID: 12441279 Free article. French.

6

[Gemcitabine and pemetrexed in genito-urinary tumors treatment].

Fléchon A. Fléchon A. Bull Cancer. 2007;94 Spec No Actualites:S116-21. Bull Cancer. 2007. PMID: 17845980 Review. French.

7

Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.

Fléchon A, Tavernier E, Boyle H, Meeus P, Rivoire M, Droz JP. Fléchon A, et al. BJU Int. 2010 Sep;106(6):779-85. doi: 10.1111/j.1464-410X.2009.09175.x. Epub 2010 Jan 19. BJU Int. 2010. PMID: 20089110

8

Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.

You B, Fronton L, Boyle H, Droz JP, Girard P, Tranchand B, Ribba B, Tod M, Chabaud S, Coquelin H, Fléchon A. You B, et al. Among authors: flechon a. Urology. 2010 Aug;76(2):423-9.e2. doi: 10.1016/j.urology.2010.02.049. Epub 2010 May 15. Urology. 2010. PMID: 20472276

9

[Uncommon bladder tumours].

Boyle H, Fléchon A, Droz JP. Boyle H, et al. Among authors: flechon a. Bull Cancer. 2010;97 Suppl Cancer de la vessie:51-7. doi: 10.1684/bdc.2010.1097. Bull Cancer. 2010. PMID: 20534390 French.

10

Treatment of uncommon malignant tumours of the bladder.

Boyle H, Fléchon A, Droz JP. Boyle H, et al. Among authors: flechon a. Curr Opin Urol. 2011 Sep;21(5):309-14. doi: 10.1097/MOU.0b013e3283495758. Curr Opin Urol. 2011. PMID: 21814051 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters